Abstract
Extraaxial tumors of the nervous system are extra-cerebral and often benign. Meningiomas, schwannomas and metastasis are the part of this group. The onset of a tumor occurs from the accumulation of genetic and epigenetic alterations in cells. To understand the molecular mechanism of tumor progression and metastasis formation is essential to identify the genes that accumulate these alterations. This study aimed at evaluating, through a case-control study, the influence of SNPs TP53 Pro47Ser and Arg72Pro, EGF + 61 and GSTP-1 Ile105Val on the development and prognosis of these tumors. Through the analysis of the polymorphisms Pro47Ser and Arg72Pro of the gene TP53, it was noticed that the polymorphic variant Ser47 is strongly associated with patients with extraaxial tumors and the presence of the variants Ser47 and Pro72 increase the risk of these tumors. Regarding the gene GSTP-1, it was concluded that the Val105 allele was more frequent among subjects with cancer and the presence of this allele in the population studied increased the risk of cancer in almost 6-fold. Finally, it was observed that the frequency of wild genotype G/G of the polymorphism EGF + 61 was higher among patients (particularly among those with low grade tumors) than among the control group and the presence of this allele may influence the risk of developing meningiomas, schwannomas and metastases in the subjects studied.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Araujo A, Ribeiro R, Azevedo I, Coelho A, Soares M, Sousa B, Pinto D, Lopes C, Medeiros R, Scagliotti GV (2007) Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer – a review of the literature. Oncologist 12:201–210
Biros E, Kalina I, Kohut A, Bogyiova E, Salagovic J, Sulla I (2002) Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients. Physiol Res 51:59–64
Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA (2007) Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer 109:1668–1675
Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, Pardal F, Suriano G, Machado JC, Lopes JM, Reis RM (2007) Association between functional EGF + 61 polymorphism and glioma risk. Clin Cancer Res 13:2621–2626
De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA (2003) Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 12:14–22
Drevelegas A (2005) Extra-axial brain tumors. Eur Radiol 15:453–467
Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC (1993) Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet 53:752–759
Hadhri-Guiga B, Toumi N, Khabir A, Sellami-Boudawara T, Ghorbel A, Daoud J, Frikha M, Gargouri A, Mokdad-Gargouri R (2007) Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Cancer Genet Cytogenet 178:89–93
Hanemann CO, Evans DG (2006) News on the genetics, epidemiology, medical care and translational research of Schwannomas. J Neurol 253:1533–1541
Harari PM, Allen GW, Bonner JA (2007) Biology of interactions: antiepidermal growth factor receptor agents. J Clin Oncol 25:4057–4065
Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Criniere E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY (2007) TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors. Cancer Genet Cytogenet 177:103–107
Leite JL, Manfrinatto JA, Mazzali M, Ward LS (2006) Polymorphisms at exon 4 of p53 and the susceptibility to herpesvirus types 6 and 1 infection in renal transplant recipients. Transpl Int 19:732–737
Li X, Dumont P, Della Pietra A, Shetler C, Murphy ME (2005) The codon 47 polymorphism in p53 is functionally significant. J Biol Chem 280:24245–24251
Lusis E, Gutmann DH (2004) Meningioma: an update. Curr Opin Neurol 17:687–692
Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C (2008) Meningioma. Crit Rev Oncol Hematol 67:153–171
Moyer AM, Salavaggione OE, Wu TY, Moon I, Eckloff BW, Hildebrandt MA, Schaid DJ, Wieben ED, Weinshilboum RM (2008) Glutathione s-transferase p1: gene sequence variation and functional genomic studies. Cancer Res 68:4791–4801
Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93–108
Pinto GR, Yoshioka FK, Clara CA, Santos MJ, Almeida JR, Burbano RR, Rey JA, Casartelli C (2008) WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil. J Neurooncol 90:253–258
Puttonen S, Keltikangas-Jarvinen L, Elovainio M, Kivimaki M, Rontu R, Lehtimaki T (2007) Temperamental activity and epidermal growth factor A61G polymorphism in Finnish adults. Neuropsychobiology 56:208–212
Rufini V, Salvatori M, Fadda G, Pinnarelli L, Castaldi P, Maussier ML, Galli G (2007) Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 110:1209–1217
Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18:1285–1289
Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, Mcpherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928–933
Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, Rannug A, Auvinen A, Christensen HC, Henriksson R, Johansen C, Lindholm C, Malmer B, Salminen T, Schoemaker MJ, Swerdlow AJ, Feychting M (2007) An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev 16:559–565
Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC, Hutchinson PE, Osborne JE, Lear JT, Smith AG, Hutchinson IV (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359:397–401
Smigielski EM, Sirotkin K, Ward M, Sherry ST (2000) dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res 28:352–355
Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40:874–891
Suh Y, Vijg J (2005) SNP discovery in associating genetic variation with human disease phenotypes. Mutat Res 573:41–53
Vauleon E, Auger N, Amiel AB, Donadey FL, Kaloshi G, Lejeune J, Delattre JY, Thillet J, Sanson M (2007) The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 172:33–37
Wang Y, Tian T, Hu Z, Tang J, Wang S, Wang X, Qin J, Huo X, Gao J, Ke Q, Jin G, Ma H, Wang X, Shen H (2008) EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women. Breast Cancer Res Treat 111:321–327
Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114:249–256
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
de Almeida, L.O. (2012). Extraaxial Brain Tumors: The Role of Genetic Polymorphisms. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 4. Tumors of the Central Nervous System, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1706-0_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-1706-0_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1705-3
Online ISBN: 978-94-007-1706-0
eBook Packages: MedicineMedicine (R0)